Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Operating Leases (2019 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Operating Leases for 3 consecutive years, with $680526.0 as the latest value for Q3 2021.

  • Quarterly Operating Leases rose 86.9% to $680526.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $680526.0 through Sep 2021, up 86.9% year-over-year, with the annual reading at $348388.0 for FY2020, 1.63% up from the prior year.
  • Operating Leases for Q3 2021 was $680526.0 at ENDRA Life Sciences, down from $709385.0 in the prior quarter.
  • The five-year high for Operating Leases was $709385.0 in Q2 2021, with the low at $331520.0 in Q1 2021.
  • Average Operating Leases over 3 years is $441258.9, with a median of $361514.0 recorded in 2019.
  • Peak annual rise in Operating Leases hit 86.9% in 2021, while the deepest fall reached 15.95% in 2021.
  • Over 3 years, Operating Leases stood at $342812.0 in 2019, then rose by 1.63% to $348388.0 in 2020, then skyrocketed by 95.34% to $680526.0 in 2021.
  • According to Business Quant data, Operating Leases over the past three periods came in at $680526.0, $709385.0, and $331520.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.